Shlomo Lewkowicz,Daniel Gat,Yehudit Kraizer,Zvika Gilad,David Leuw,Gavriel Meron,Arkady Glukhovsky,Howard D. Manten
申请号:
US12687692
公开号:
US08672863B2
申请日:
2010.01.14
申请国别(地区):
US
年份:
2014
代理人:
摘要:
A system and method for indicating transferability of a non-dissolvable target in-vivo device through the GI tract are described. The in vivo system includes a dissolvable in-vivo device which has two operational phases an initial phase in which the device is of initial dimensions and a final phase in which the device is of final dimensions. In the initial phase the device can pass freely through a normally configured body lumen whereas it may not be able to pass freely through an abnormally configured lumen. In the final phase the device can pass freely through a body lumen even if it is abnormally configured.